Agilent Technologies Other Current Assets 2010-2025 | A
Agilent Technologies other current assets from 2010 to 2025. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Agilent Technologies other current assets for the quarter ending April 30, 2025 were $365M, a 28.98% increase year-over-year.
- Agilent Technologies other current assets for 2024 were $0.334B, a 21.9% increase from 2023.
- Agilent Technologies other current assets for 2023 were $0.274B, a 2.84% decline from 2022.
- Agilent Technologies other current assets for 2022 were $0.282B, a 27.03% increase from 2021.
| Agilent Technologies Annual Other Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $334 |
| 2023 | $274 |
| 2022 | $282 |
| 2021 | $222 |
| 2020 | $216 |
| 2019 | $198 |
| 2018 | $187 |
| 2017 | $192 |
| 2016 | $182 |
| 2015 | $294 |
| 2014 | $263 |
| 2013 | $343 |
| 2012 | $341 |
| 2011 | $284 |
| 2010 | $385 |
| 2009 | $321 |
| Agilent Technologies Quarterly Other Current Assets (Millions of US $) |
|
|---|---|
| 2025-04-30 | $365 |
| 2025-01-31 | $315 |
| 2024-10-31 | $334 |
| 2024-07-31 | $272 |
| 2024-04-30 | $283 |
| 2024-01-31 | $262 |
| 2023-10-31 | $274 |
| 2023-07-31 | $290 |
| 2023-04-30 | $270 |
| 2023-01-31 | $258 |
| 2022-10-31 | $282 |
| 2022-07-31 | $258 |
| 2022-04-30 | $262 |
| 2022-01-31 | $232 |
| 2021-10-31 | $222 |
| 2021-07-31 | $264 |
| 2021-04-30 | $268 |
| 2021-01-31 | $312 |
| 2020-10-31 | $216 |
| 2020-07-31 | $211 |
| 2020-04-30 | $211 |
| 2020-01-31 | $204 |
| 2019-10-31 | $198 |
| 2019-07-31 | $176 |
| 2019-04-30 | $181 |
| 2019-01-31 | $169 |
| 2018-10-31 | $187 |
| 2018-07-31 | $180 |
| 2018-04-30 | $166 |
| 2018-01-31 | $151 |
| 2017-10-31 | $192 |
| 2017-07-31 | $189 |
| 2017-04-30 | $186 |
| 2017-01-31 | $190 |
| 2016-10-31 | $182 |
| 2016-07-31 | $198 |
| 2016-04-30 | $192 |
| 2016-01-31 | $297 |
| 2015-10-31 | $294 |
| 2015-07-31 | $274 |
| 2015-04-30 | $291 |
| 2015-01-31 | $361 |
| 2014-10-31 | $263 |
| 2014-07-31 | $453 |
| 2014-04-30 | $424 |
| 2014-01-31 | $394 |
| 2013-10-31 | $343 |
| 2013-07-31 | $325 |
| 2013-04-30 | $341 |
| 2013-01-31 | $348 |
| 2012-10-31 | $341 |
| 2012-07-31 | $302 |
| 2012-04-30 | $258 |
| 2012-01-31 | $302 |
| 2011-10-31 | $284 |
| 2011-07-31 | $308 |
| 2011-04-30 | $350 |
| 2011-01-31 | $292 |
| 2010-10-31 | $385 |
| 2010-07-31 | $389 |
| 2010-04-30 | $288 |
| 2010-01-31 | $297 |
| 2009-10-31 | $321 |
| 2009-07-31 | $283 |
| 2009-04-30 | $294 |
| 2009-01-31 | $343 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.241B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $221.464B | 25.98 |
| Boston Scientific (BSX) | United States | $155.948B | 37.25 |
| Stryker (SYK) | United States | $144.198B | 29.40 |
| EssilorLuxottica (ESLOY) | France | $136.878B | 0.00 |
| Medtronic (MDT) | Ireland | $114.582B | 16.24 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.915B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.396B | 24.77 |
| ResMed (RMD) | United States | $40.938B | 29.24 |
| GE HealthCare Technologies (GEHC) | United States | $31.891B | 14.99 |
| Koninklijke Philips (PHG) | Netherlands | $25.479B | 16.85 |
| Terumo (TRUMY) | Japan | $25.170B | 32.69 |
| Insulet (PODD) | United States | $20.051B | 78.70 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.929B | 11.51 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.503B | 0.00 |
| Baxter (BAX) | United States | $11.269B | 8.71 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.745B | 28.29 |
| Lantheus Holdings (LNTH) | United States | $4.882B | 12.32 |
| Perrigo (PRGO) | Ireland | $3.662B | 9.28 |
| Prestige Consumer Healthcare (PBH) | United States | $3.643B | 16.27 |
| Haemonetics (HAE) | United States | $3.592B | 16.36 |
| Envista Holdings (NVST) | United States | $3.530B | 24.22 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.136B | 23.12 |
| LeMaitre Vascular (LMAT) | United States | $1.831B | 40.93 |
| AtriCure (ATRC) | United States | $1.710B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.543B | 10.61 |
| Green Thumb Industries (GTBIF) | United States | $1.429B | 32.14 |
| Acuren (TIC) | United States | $1.340B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| Phibro Animal Health (PAHC) | United States | $1.058B | 13.53 |
| Neogen (NEOG) | United States | $1.012B | 16.07 |
| BioLife Solutions (BLFS) | United States | $0.995B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.954B | 0.00 |
| InMode (INMD) | Israel | $0.868B | 8.04 |
| Kestra Medical Technologies (KMTS) | United States | $0.790B | 0.00 |
| Valneva SE (VALN) | France | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.590B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.572B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| ZimVie (ZIMV) | United States | $0.522B | 20.39 |
| Surmodics (SRDX) | United States | $0.515B | 0.00 |
| CeriBell (CBLL) | United States | $0.511B | 0.00 |
| Owens & Minor (OMI) | United States | $0.508B | 4.21 |
| SNDL (SNDL) | Canada | $0.434B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.361B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.311B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.304B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.296B | 10.88 |
| Quanterix (QTRX) | United States | $0.293B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.67 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.239B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.234B | 19.77 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Omeros (OMER) | United States | $0.223B | 0.00 |
| Brainsway (BWAY) | Israel | $0.217B | 57.35 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.215B | 0.00 |
| Biote (BTMD) | United States | $0.213B | 5.98 |
| Vireo Growth (VREOF) | United States | $0.196B | 0.00 |
| Exagen (XGN) | United States | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.69 |
| Organigram Global (OGI) | Canada | $0.178B | 0.00 |
| High Tide (HITI) | Canada | $0.176B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.158B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
| Safety Shot (SHOT) | United States | $0.122B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.117B | 14.45 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.51 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Apyx Medical (APYX) | United States | $0.066B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Zynex (ZYXI) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.71 |
| Nephros (NEPH) | United States | $0.036B | 48.86 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |